CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 26 filers reported holding CARDIOME PHARMA CORP in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $1,000 | – | 504 | 0.0% | 0.00% | – |
Q4 2017 | $0 | -100.0% | 504 | -49.8% | 0.00% | – |
Q3 2017 | $2,000 | -50.0% | 1,004 | +25.5% | 0.00% | – |
Q2 2017 | $4,000 | -80.0% | 800 | -88.2% | 0.00% | – |
Q1 2017 | $20,000 | +11.1% | 6,752 | 0.0% | 0.00% | – |
Q4 2016 | $18,000 | -18.2% | 6,752 | 0.0% | 0.00% | – |
Q3 2016 | $22,000 | -35.3% | 6,752 | 0.0% | 0.00% | – |
Q2 2016 | $34,000 | +30.8% | 6,752 | +4.6% | 0.00% | – |
Q1 2016 | $26,000 | -50.9% | 6,452 | -1.9% | 0.00% | – |
Q4 2015 | $53,000 | +960.0% | 6,577 | +915.0% | 0.00% | – |
Q3 2015 | $5,000 | -50.0% | 648 | -35.9% | 0.00% | – |
Q2 2015 | $10,000 | 0.0% | 1,011 | -0.5% | 0.00% | – |
Q1 2015 | $10,000 | 0.0% | 1,016 | -0.6% | 0.00% | – |
Q4 2014 | $10,000 | +11.1% | 1,022 | -0.8% | 0.00% | – |
Q3 2014 | $9,000 | +125.0% | 1,030 | +106.0% | 0.00% | – |
Q2 2014 | $4,000 | 0.0% | 500 | -3.8% | 0.00% | – |
Q1 2014 | $4,000 | +33.3% | 520 | +4.0% | 0.00% | – |
Q4 2013 | $3,000 | +50.0% | 500 | 0.0% | 0.00% | – |
Q3 2013 | $2,000 | +100.0% | 500 | -26.5% | 0.00% | – |
Q2 2013 | $1,000 | – | 680 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 1,918,722 | $6,006,000 | 4.90% |
Tamarack Advisers, LP | 4,400,000 | $13,882,000 | 2.18% |
AlphaOne Investment Services, LLC | 580,965 | $1,824,000 | 0.60% |
CLOUGH CAPITAL PARTNERS L P | 3,061,064 | $9,581,000 | 0.50% |
Rock Springs Capital Management LP | 1,200,000 | $3,751,000 | 0.24% |
TURNER INVESTMENTS LLC | 150,000 | $470,000 | 0.16% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 5,397,007 | $16,893,000 | 0.14% |
SABBY MANAGEMENT, LLC | 484,505 | $1,521,000 | 0.06% |
PUTNAM INVESTMENTS LLC | 3,673,622 | $11,536,000 | 0.03% |
ARDSLEY ADVISORY PARTNERS LP | 28,900 | $90,000 | 0.01% |